Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03752203 · ClinicalTrials.gov registry record · NA
Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors
A NA study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03752203 is a NA study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 2 participants.
The verdict
NCT03752203, a NA study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Sodium fluorescein, which has been shown to be useful for intraoperative guidance regarding the resection of adult neurosurgical tumors, can aid the resection of pediatric neurosurgical tumors.
Interventions
- DRUG Sodium Fluorescein
- DEVICE Microscopic Resection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-08-11 |
| Est. Completion | 2023-06-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03752203
The ClinicalTrials.gov registry entry for NCT03752203 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sodium Fluorescein is the first listed.
NCT03752203 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03752203 about?
NCT03752203 is a clinical study titled "Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors". Sodium fluorescein, which has been shown to be useful for intraoperative guidance regarding the resection of adult neurosurgical tumors, can aid the resection of pediatric neurosurgical tumors.
What is the current status of trial NCT03752203?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2021-08-11. Estimated completion is 2023-06-29.
What interventions are being tested in trial NCT03752203?
The interventions under investigation include: Sodium Fluorescein (DRUG), Microscopic Resection (DEVICE).
Who is sponsoring clinical trial NCT03752203?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.